Blood stem cell transplantationWINTER, Jane N.Cancer treatment and research. 1997, Vol 77, issn 0927-3042, 426 p.Serial Issue

Defining the role of immunotherapy and radioimmunotherapy in the treatment of low-grade lymphomaWINTER, Jane N.Current opinion in hematology. 2007, Vol 14, Num 4, pp 360-368, issn 1065-6251, 9 p.Article

Current controversies in follicular lymphomaAURORA, Vikas; WINTER, Jane N.Blood reviews. 2006, Vol 20, Num 4, pp 179-200, issn 0268-960X, 22 p.Article

Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomasCILLEY, Jeffrey; WINTER, Jane N.Haematologica (Roma). 2006, Vol 91, Num 1, pp 114-120, issn 0390-6078, 7 p.Article

The use of unrelated donors for bone marrow transplantationTRICOT, G.Cancer treatment and research. 1997, Vol 77, pp 217-228, issn 0927-3042Article

Graft-versus-host disease : implications from basic immunology for prophylaxis and treatmentVOGELSANG, G. B.Cancer treatment and research. 1997, Vol 77, pp 87-97, issn 0927-3042Article

Autologous stem cell transplantation for the treatment of chronic myelogenous leukemiaBHATIA, R; MCGLAVE, P. B.Cancer treatment and research. 1997, Vol 77, pp 357-374, issn 0927-3042Article

Supportive care in bone marrow transplantation : pulmonary complicationsCRAWFORD, S. W.Cancer treatment and research. 1997, Vol 77, pp 231-254, issn 0927-3042Article

Autologous bone marrow transplantation in pediatric solid tumorsKLETZEL, M; KIM, A. R.Cancer treatment and research. 1997, Vol 77, pp 333-356, issn 0927-3042Article

Allogeneic umbilical cord blood transplantationWAGNER, J. E.Cancer treatment and research. 1997, Vol 77, pp 187-216, issn 0927-3042Article

Recombinant cytokines and hematopoietic growth factors in allogeneic and autologous bone marrow transplantationLAZARUS, H. M.Cancer treatment and research. 1997, Vol 77, pp 255-301, issn 0927-3042Article

Gene therapy of solid tumors and hematopoietic neoplasmsBACHIER, C. R; DEISSEROTH, A. B.Cancer treatment and research. 1997, Vol 77, pp 3-26, issn 0927-3042Article

Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusionsPORTER, D. L; ANTIN, J. H.Cancer treatment and research. 1997, Vol 77, pp 57-85, issn 0927-3042Article

The detection of minimal residual disease : implications for bone marrow transplantationGRIBBEN, J. G; SCHULTZE, J. L.Cancer treatment and research. 1997, Vol 77, pp 99-120, issn 0927-3042Article

ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's LymphomaMEYER, Ralph M; GOSPODAROWICZ, Mary K; CONNORS, Joseph M et al.The New England journal of medicine. 2012, Vol 366, Num 5, pp 399-408, issn 0028-4793, 10 p.Article

Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial- independent mechanismsBHALLA, Savita; GORDON, Leo I; EVENS, Andrew M et al.British journal of haematology. 2010, Vol 150, Num 3, pp 365-369, issn 0007-1048, 5 p.Article

Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin familyEVENS, Andrew M; SCHUMACKER, Paul T; HOLMGREN, Arne et al.British journal of haematology. 2008, Vol 141, Num 5, pp 676-680, issn 0007-1048, 5 p.Article

The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignanciesMATTHEWS, D. C; APPELBAUM, F. R; PRESS, O. W et al.Cancer treatment and research. 1997, Vol 77, pp 121-139, issn 0927-3042Article

Ex vivo expansion of hematopoietic stem and progenitor cells for transplantationLAIUPPA, J. A; PAPOUTSAKIS, E. T; MILLER, W. M et al.Cancer treatment and research. 1997, Vol 77, pp 159-186, issn 0927-3042Article

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II TrialARMAND, Philippe; NAGLER, Arnon; FAY, Joseph W et al.Journal of clinical oncology. 2013, Vol 31, Num 33, pp 4199-4206, issn 0732-183X, 8 p.Article

Clinical, Morphologic, Immunophenotypic, and Molecular Cytogenetic Assessment of CD4-/CD8- γδ T-Cell Large Granular Lymphocytic LeukemiaCHEN, Yi-Hua; CHADBURN, Amy; EVENS, Andrew M et al.American journal of clinical pathology. 2011, Vol 136, Num 2, pp 289-299, issn 0002-9173, 11 p.Article

A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma. CommentaryNADEMANEE, Auayporn; FORMAN, Stephen; KRISHNAN, Amrita et al.Blood. 2005, Vol 106, Num 8, pp 2601-2602, issn 0006-4971, 9 p.Article

Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II studyEVENS, Andrew M; SMITH, Mitchell R; LOSSOS, Izidore S et al.British journal of haematology. 2014, Vol 166, Num 4, pp 514-520, issn 0007-1048, 7 p.Article

Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular LymphomaSCHUSTER, Stephen J; NEELAPU, Sattva S; MCGAUGHEY, Dean S et al.Journal of clinical oncology. 2011, Vol 29, Num 20, pp 2787-2794, issn 0732-183X, 8 p.Article

CD23+ Mantle Cell Lymphoma : A Clinical Pathologic Entity Associated With Superior Outcome Compared With CD23-DiseaseKELEMEN, Katalin; PETERSON, Loann C; GORDON, Leo I et al.American journal of clinical pathology. 2008, Vol 130, Num 2, pp 166-177, issn 0002-9173, 12 p.Article